{"transactions":[{"id":1687673,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:07:20.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":228000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award will vest in 36 equal monthly installments, so that it shall be fully vested on January 2, 2027."}],"balance_after":228000,"derivative":{"exercise_price":0.6552,"expiration_date":"2034-01-01","underlying":"Common  Stock","underlying_shares":228000},"source":{"system":"sec-edgar","filing":"0001453687-24-000024","document":"wk-form4_1704406012.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368724000024/wk-form4_1704406012.xml","form_type":"4"}},{"id":1687672,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common  Stock","published_at":"2024-01-04T22:07:20.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":178000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in three equal annual installments so that the underlying shares will be fully vested on January 2, 2027."}],"balance_after":178000,"source":{"system":"sec-edgar","filing":"0001453687-24-000024","document":"wk-form4_1704406012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368724000024/wk-form4_1704406012.xml","form_type":"4"}},{"id":1740609,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T22:17:43.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":75000,"price":0.93,"value":69750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, which provided for vesting in full on January 2, 2024, was canceled in the Merger in exchange for a cash payment of $69,750, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.13,"expiration_date":"2033-01-01","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001453687-23-000084","document":"wk-form4_1700086654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000084/wk-form4_1700086654.xml","form_type":"4"}},{"id":1740608,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T22:17:43.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":3.31,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001453687-23-000084","document":"wk-form4_1700086654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000084/wk-form4_1700086654.xml","form_type":"4"}},{"id":1740607,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T22:17:43.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":4.01,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001453687-23-000084","document":"wk-form4_1700086654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000084/wk-form4_1700086654.xml","form_type":"4"}},{"id":1740606,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T22:17:43.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":3,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001453687-23-000084","document":"wk-form4_1700086654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000084/wk-form4_1700086654.xml","form_type":"4"}},{"id":1740605,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T22:17:43.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option, which provided for vesting in full on June 14, 2020, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting in full on June 14, 2020, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":2.1,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001453687-23-000084","document":"wk-form4_1700086654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000084/wk-form4_1700086654.xml","form_type":"4"}},{"id":1740604,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T22:17:43.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option, which provided for vesting in full on June 13, 2019, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided for vesting in full on June 13, 2019, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":12.75,"expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001453687-23-000084","document":"wk-form4_1700086654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000084/wk-form4_1700086654.xml","form_type":"4"}},{"id":1740603,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T22:17:43.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6410,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option, which provided for vesting in full on June 14, 2018, was canceled in the merger (the \"Merger\") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, which provided for vesting in full on June 14, 2018, was canceled in the merger (the \"Merger\") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc."}],"balance_after":0,"derivative":{"exercise_price":17.47,"expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":6410},"source":{"system":"sec-edgar","filing":"0001453687-23-000084","document":"wk-form4_1700086654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000084/wk-form4_1700086654.xml","form_type":"4"}},{"id":2067120,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T22:00:20.000Z","date":"2023-01-02","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Common Stock underlying this award will vest in full on January 2, 2024."}],"balance_after":75000,"derivative":{"exercise_price":1.13,"expiration_date":"2033-01-01","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001453687-23-000017","document":"wf-form4_167286958364872.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368723000017/wf-form4_167286958364872.xml","form_type":"4"}},{"id":2443744,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T21:35:04.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Common Stock underlying this award will vest in full on January 3, 2023."}],"balance_after":40000,"derivative":{"exercise_price":3.31,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001453687-22-000022","document":"wf-form4_164141848053037.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368722000022/wf-form4_164141848053037.xml","form_type":"4"}},{"id":2763853,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-01T22:32:46.000Z","date":"2021-03-30","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on March 30, 2022."}],"balance_after":40000,"derivative":{"exercise_price":4.01,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001453687-21-000047","document":"wf-form4_161731631340894.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368721000047/wf-form4_161731631340894.xml","form_type":"4"}},{"id":3101875,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T20:47:29.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 19, 2021 or the day immediately prior to the company's 2021 annual meeting of stockholders."}],"balance_after":20000,"derivative":{"exercise_price":3,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001453687-20-000078","document":"wf-form4_159294523160862.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368720000078/wf-form4_159294523160862.xml","form_type":"4"}},{"id":3486123,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-18T20:22:04.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 14, 2020 or the day immediately prior to the company's 2020 annual meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":2.1,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001453687-19-000073","document":"wf-form4_156088930979080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000145368719000073/wf-form4_156088930979080.xml","form_type":"4"}},{"id":3888595,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-19T23:02:52.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 15, 2019 or the day immediately prior to the company's 2019 annual meeting of shareholders."}],"balance_after":10000,"derivative":{"exercise_price":12.75,"expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001638599-18-000672","document":"doc4_5486.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859918000672/doc4_5486.xml","form_type":"4"}},{"id":4276115,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":95472,"kind":"person","name":"Sallin Aymeric","position":1,"cik":"0001677660","reported_name":"Sallin Aymeric","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-20T20:42:20.000Z","date":"2017-06-16","kind":"grant","acquired":true,"shares":6410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 16, 2018 or the day immediately prior to the company's 2018 annual meeting of shareholders."}],"balance_after":6410,"derivative":{"exercise_price":17.47,"expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":6410},"source":{"system":"sec-edgar","filing":"0001638599-17-000639","document":"doc4_4807.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000639/doc4_4807.xml","form_type":"4"}}]}